Investors and Media

SEC Filing Details

Document Details

Form
Filing Date
Mar 31, 2022
Document Date
Mar 21, 2022
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
4D Molecular Therapeutics
Issuer
4D MOLECULAR THERAPEUTICS, INC.
Filer
BIZILY SCOTT